COPD Press Release

Title Picture
09/24/2018 - 17:16
VA researchers work to create 3D-printed artificial lung that may revolutionize treatment of Veterans with lung disease
US Veterans Affairs's picture
US Veterans Affairs
09/21/2018 - 09:57
Trelegy Ellipta receives positive CHMP opinion supporting expanded COPD indication in Europe
GlaxoSmithKline's picture
GlaxoSmithKline
09/18/2018 - 12:37
Fasenra shows consistent safety and sustained efficacy in long-term Phase III BORA trial in severe eosinophilic asthma
AstraZeneca's picture
AstraZeneca
09/17/2018 - 11:31
The UK's leading mental health experts unite to solve treatment challenges
KingsCollege's picture
KingsCollege
09/17/2018 - 03:47
Print Theravance Biopharma and Mylan Report New Data from Phase 3 Studies of YUPELRI (revefenacin) in Oral Presentation at the European Respiratory Society International Congress
Mylan's picture
Mylan
09/16/2018 - 13:04
The Lancet Respiratory Medicine publishes first Phase III trial for PT010 triple combination therapy in moderate to very severe chronic obstructive pulmonary disease
AstraZeneca's picture
AstraZeneca
09/13/2018 - 01:46
AstraZeneca to present Fasenra long-term safety and efficacy data at European Respiratory Society International Congress 2018
AstraZeneca's picture
AstraZeneca
09/11/2018 - 16:09
Theravance Biopharma and Mylan to Report New Data from Phase 3 Studies of YUPELRI (revefenacin) in Oral Presentation at European Respiratory Society International Congress 2018
Mylan's picture
Mylan
09/10/2018 - 18:58
GSK data presented at ERS further supports its industry-leading respiratory medicines portfolio
GlaxoSmithKline's picture
GlaxoSmithKline
09/10/2018 - 16:41
GSK announces results of indirect treatment comparisons of Nucala to benralizumab and reslizumab for severe eosinophilic asthma
GlaxoSmithKline's picture
GlaxoSmithKline
09/07/2018 - 18:03
GSK receives complete response letter from US FDA for use of mepolizumab in COPD patients
GlaxoSmithKline's picture
GlaxoSmithKline
09/07/2018 - 16:42
Tezepelumab granted Breakthrough Therapy Designation by US FDA
AstraZeneca's picture
AstraZeneca
08/30/2018 - 16:52
Testosterone replacement therapy may slow the progression of COPD
UTMB's picture
UTMB
08/30/2018 - 14:11
European Commission approves Nucala (mepolizumab) for the treatment of children with severe asthma
GlaxoSmithKline's picture
GlaxoSmithKline
08/23/2018 - 18:13
Northwest Primary Care takes a proactive approach to value
Greenway Medical's picture
Greenway Medical
08/23/2018 - 00:27
AstraZeneca provides update on AERISTO Phase IIIb trial for Bevespi Aerosphere in chronic obstructive pulmonary disease
AstraZeneca's picture
AstraZeneca
08/16/2018 - 17:14
Childhood Exposure to Secondhand Smoke May Increase Risk of Adult Lung Disease Death
American Cancer Society's picture
American Cancer...
08/14/2018 - 17:04
Morristown Medical Center Rated Number One Hospital in New Jersey by U.S. News & World Report
Atlantic Health System's picture
Atlantic Health...
08/14/2018 - 08:02
E-cigarette vapour disables key immune cells in the lung and boosts inflammation
University of Birmingham's picture
University of B...
08/14/2018 - 06:26
Bayer and Haplogen collaborate to develop new treatments against pulmonary diseases
bayer's picture
bayer
08/01/2018 - 11:59
Forum of International Respiratory Societies commemorates, celebrates and supports those impacted by lung cancer
American College of Chest Physicians's picture
American Colleg...
07/27/2018 - 10:44
CHMP recommend Nucala (mepolizumab) for the treatment of severe eosinophilic asthma paediatric patients in Europe
GlaxoSmithKline's picture
GlaxoSmithKline
07/25/2018 - 12:51
GSK reports on outcome of the FDA Advisory Committee on mepolizumab for the treatment of COPD patients on maximum inhaled therapy
GlaxoSmithKline's picture
GlaxoSmithKline
07/25/2018 - 03:06
GSK delivers improvements in sales, margins and cash flow in Q2 2018
GlaxoSmithKline's picture
GlaxoSmithKline
07/12/2018 - 18:02
Blood biomarker can help predict disease progression in patients with COPD
American College of Chest Physicians's picture
American Colleg...
06/29/2018 - 16:16
Study Links Time Spent Sitting to Higher Risk of Death from 14 Diseases
American Cancer Society's picture
American Cancer...
06/26/2018 - 20:17
Significant Reductions in Costly Pulmonary Complications with Use of Drug-Free Device
staronepr's picture
staronepr
06/19/2018 - 14:33
Low Vitamin D Levels Associated with Scarring Lung Disease
Johns Hopkins Health System's picture
Johns Hopkins H...
06/11/2018 - 19:45
Vital research into incurable lung condition affecting millions to take place in Birmingham
University of Birmingham's picture
University of B...
06/05/2018 - 12:09
The primary health issues of smoking
BAT's picture
BAT
06/04/2018 - 20:37
BWF Invests $9.1 Million in the Careers of Physician-Scientists
BW Fund's picture
BW Fund
05/30/2018 - 09:52
Update on TERRANOVA Phase III trial for Fasenra in chronic obstructive pulmonary disease
AstraZeneca's picture
AstraZeneca
05/29/2018 - 06:24
GSK submits regulatory application in Japan for once-daily single inhaler triple therapy FF/UMEC/VI for patients with COPD
GlaxoSmithKline's picture
GlaxoSmithKline
05/21/2018 - 10:11
GSK receives US approval of Arnuity Ellipta for use in children from 5 years old who suffer from asthma
GlaxoSmithKline's picture
GlaxoSmithKline
05/21/2018 - 03:26
Nucala (mepolizumab) study reports long-term safety data, consistent exacerbation reduction and improved asthma control
GlaxoSmithKline's picture
GlaxoSmithKline
05/18/2018 - 07:48
Illinois residents invited to the Lung Health Experience at Daley Plaza
American College of Chest Physicians's picture
American Colleg...
05/17/2018 - 06:35
New England Journal of Medicine publishes two trials for Symbicort as an anti-inflammatory reliever therapy as needed in mild asthma
AstraZeneca's picture
AstraZeneca
05/16/2018 - 03:04
GSKs industry-leading respiratory research and scientific innovation showcased at ATS conference
GlaxoSmithKline's picture
GlaxoSmithKline
05/16/2018 - 01:50
AstraZeneca is advancing clinical practice in respiratory medicine with new data at the American Thoracic Society 2018 International Congress
AstraZeneca's picture
AstraZeneca
05/11/2018 - 01:16
AstraZeneca provides update on GALATHEA Phase III trial for Fasenra in chronic obstructive pulmonary disease
AstraZeneca's picture
AstraZeneca
05/02/2018 - 06:51
Blue Cross and Blue Shield of Texas Joins Forces with IT'S TIME TEXAS to Fight Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease
Blue Cross Blue Shield Association's picture
Blue Cross Blue...
05/01/2018 - 13:03
Never Too Early, Never Too Late. Its Always the Right Time to Address Airways Disease
American College of Chest Physicians's picture
American Colleg...
04/24/2018 - 10:16
Once-daily Trelegy Ellipta gains expanded indication in the US for the treatment of patients with COPD
GlaxoSmithKline's picture
GlaxoSmithKline
04/18/2018 - 15:59
Landmark IMPACT study published in NEJM shows significant benefits of Trelegy Ellipta for patients with COPD
GlaxoSmithKline's picture
GlaxoSmithKline
04/18/2018 - 09:20
New innovation hub aims to take a 'moon shot' at cystic fibrosis
University of Cambridge's picture
University of C...
04/10/2018 - 17:22
Delivery system considerations for inhaled medications undermined in patients with COPD
American College of Chest Physicians's picture
American Colleg...
04/06/2018 - 00:34
Quantitative Imaging Workshop XV
Prevent Cancer Foundation's picture
Prevent Cancer ...
04/04/2018 - 21:38
Three-quarters of COPD cases are linked to childhood risk factors that are exacerbated in adulthood
University of Bristol's picture
University of B...
04/04/2018 - 15:27
Practicing Tai Chi helps improve respiratory function in patients with COPD
American College of Chest Physicians's picture
American Colleg...
03/08/2018 - 03:42
GSK announces positive EU approval for labelling update to Relvar Ellipta in patients with asthma
GlaxoSmithKline's picture
GlaxoSmithKline
03/06/2018 - 13:22
BODE may overestimate transplant benefit in COPD patients
American College of Chest Physicians's picture
American Colleg...
03/05/2018 - 07:44
Nucala (mepolizumab) improved asthma control in patients uncontrolled on Xolair (omalizumab)
GlaxoSmithKline's picture
GlaxoSmithKline
03/02/2018 - 10:22
Perficient to Showcase Healthcare Data Integration and Analytics Solutions at HIMSS 2018
Perficient's picture
Perficient
03/01/2018 - 11:33
Grifols Shines Light on Rare Disease with Launch of Educational Campaign "Look Into Genetic COPD"
Grifols's picture
Grifols
02/26/2018 - 14:53
2 ER Physicians Recount Deployment in Hurricane Torn Puerto Rico
Henry Ford Health System's picture
Henry Ford Heal...
02/16/2018 - 11:44
GlobalMed Simplifies Telehealth for Clinicians with eNcounter Platform
Global Med Technologies's picture
Global Med Tech...
02/15/2018 - 12:08
NHS Scotland chooses Trustmarque and KenSci to trial innovative predictive technology for chronic obstructive pulmonary disease
Capita's picture
Capita
02/14/2018 - 05:27
GSK submits landmark IMPACT data to European Medicines Agency to support expanded label for Trelegy Ellipta
GlaxoSmithKline's picture
GlaxoSmithKline
02/07/2018 - 04:32
GSK delivers improvements in sales, margins and cash flow in 2017
GlaxoSmithKline's picture
GlaxoSmithKline
02/05/2018 - 11:43
Long-term usage of inhaled corticosteroids may increase risk of bone fractures in patients with COPD
American College of Chest Physicians's picture
American Colleg...